Evaluating intravenous fluid therapy for acute pancreatitis
Evaluation of Intravenous Fluid Therapy Within Dallas Acute Pancreatitis Protocol
This study tests whether different types and amounts of IV fluids can help people with acute pancreatitis avoid complications and feel better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Methodist Health System Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Trial ID | NCT06223594 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of intravenous fluid therapy in patients diagnosed with acute pancreatitis. It aims to determine the optimal fluid regimen, including the type and rate of administration, to prevent complications such as organ failure. The study will observe patients who meet specific inclusion criteria and follow the established fluid infusion protocol. By analyzing patient outcomes, the research seeks to clarify conflicting evidence regarding fluid resuscitation strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with acute pancreatitis.
Not a fit: Patients with chronic pancreatitis or those who did not adhere to the intravenous fluid infusion protocol may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols for acute pancreatitis, potentially reducing mortality and enhancing patient recovery.
How similar studies have performed: While there have been numerous studies on fluid therapy in acute pancreatitis, this specific evaluation of intravenous fluid regimens is crucial due to the lack of consensus on the best approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ● Age \> 18 years * Diagnosis of AP based on International Statistical Classification of Diseases( ICD)-10 code Exclusion Criteria: * ● Diagnosis of chronic pancreatitis * Patients who did not follow the IVF infusion protocol * Received \< 24 hours of IVF therapy * Transferred from another institution
Where this trial is running
Dallas, Texas
- Methodist Dallas Medical Center — Dallas, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Jessica Crotty, PharmD — Methodist Midlothian Medical Center
- Study coordinator: Bethany Brauer, MPH
- Email: MHSIRB@mhd.com
- Phone: 214-947-4681
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.